| Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) |
36 |
| The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications |
33 |
| Epidemiology, pathogenesis, and management of takotsubo syndrome |
23 |
| Electrochemical skin conductance: a systematic review |
11 |
| Autonomic dysfunction in Parkinson disease and animal models |
10 |
| Ictal autonomic changes as a tool for seizure detection: a systematic review |
9 |
| First symptoms in multiple system atrophy |
9 |
| Autonomic involvement in Guillain-Barre syndrome: an update |
9 |
| Skin nerve alpha-synuclein deposits in Parkinson's disease and other synucleinopathies: a review |
9 |
| Bladder dysfunction as the initial presentation of multiple system atrophy: a prospective cohort study |
8 |
| Autonomic aspects of sudden unexpected death in epilepsy (SUDEP) |
7 |
| Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances |
7 |
| Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management |
7 |
| Functional neuroimaging of the central autonomic network: recent developments and clinical implications |
7 |
| Ventilatory and cerebrovascular regulation and integration at high-altitude |
7 |
| The link between narcolepsy and autonomic cardiovascular dysfunction: a translational perspective |
6 |
| Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function? |
6 |
| Infectious diseases causing autonomic dysfunction |
6 |
| Complex regional pain syndrome: a focus on the autonomic nervous system |
6 |
| The endocannabinoid system in cardiovascular function: novel insights and clinical implications |
5 |
| Neural pathways involved in infection-induced inflammation: recent insights and clinical implications |
5 |
| Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis) |
5 |
| Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management |
5 |
| Autonomic regulation during sleep and wakefulness: a review with implications for defining the pathophysiology of neurological disorders |
5 |
| Neurogenic hypertension: pathophysiology, diagnosis and management |
5 |
| Assessment of sudomotor function |
5 |
| The neurobiology of human crying |
4 |
| Does resistance training modulate cardiac autonomic control? A systematic review and meta-analysis |
4 |
| Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications |
4 |
| Heart rate variability in Parkinson disease and idiopathic REM sleep behavior disorder |
4 |
| Gastrointestinal symptoms in postural tachycardia syndrome: a systematic review |
4 |
| The sacral parasympathetic: ontogeny and anatomy of a myth |
4 |
| Autonomic uprising: the tilt table test in autonomic medicine |
4 |
| Epidemiology and pathophysiology of autonomic seizures: a systematic review |
4 |
| Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities |
4 |
| Physical activity and dietary interventions in diabetic neuropathy: a systematic review |
4 |
| A practical guide to active stand testing and analysis using continuous beat-to-beat non-invasive blood pressure monitoring |
4 |
| The physical examination as a window into autonomic disorders |
3 |
| The sacral autonomic outflow is parasympathetic: Langley got it right |
3 |
| Autonomic nervous system and cancer |
3 |
| Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review |
3 |
| Cardiac sympathetic innervation in the MPTP non-human primate model of Parkinson disease |
3 |
| Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease |
3 |
| Frequency and factors related to drooling in Chinese patients with multiple system atrophy: a cross-sectional study |
3 |
| Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue |
3 |
| Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders |
3 |
| Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis |
3 |
| Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system |
3 |
| Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management |
2 |
| Seronegative autoimmune autonomic neuropathy: a distinct clinical entity |
2 |
